CNAVSNCT06192238
China National Study of Adrenal Venous Sampling
StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved at least 1 year 8 months later.
See at-risk trials from Chinese Academy of Medical Sciences, Fuwai Hospital
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Dec 30, 2026 to Aug 31, 2028 Show 5 more changesShow less
- Start date: Jan 1, 2024 to Dec 1, 2026
- Eligibility criteria expanded, about 3 words
- Study completion pushed from Dec 30, 2026 to Aug 31, 2029
- Study sites: 48 to 49
- Secondary endpoints: details revised at 2 of 9 entries
- Minor Secondary endpoints: details revised at 2 of 9 entriesv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
The success rate of bilateral adrenal venous sampling
Timeframe: At AVS procedure
Secondary (9)
The success rate of left adrenal venous sampling
The success rate of right adrenal venous sampling
Selection of intraoperative catheter
Time of the procedure
Time of fluoroscopy
Show 4 moreShow less
The contrast agent dosage
the incidence of complications
the cost of the procedure
pathological results(If the patient underwent adrenalectomy)
Arms and interventions
Adrenal Venous Sampling
Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production.
Procedures: adrenal venous sampling
Sites
49 sites in 1 country